Literature DB >> 34935162

Epigenetic regulation of inflammation by CxxC domain-containing proteins.

Atsushi Onodera1,2, Masahiro Kiuchi1, Kota Kokubo1, Toshinori Nakayama1,3.   

Abstract

Epigenetic regulation of gene transcription in the immune system is important for proper control of protective and pathogenic inflammation. Aberrant epigenetic modifications are often associated with dysregulation of the immune cells, including lymphocytes and macrophages, leading to pathogenic inflammation and autoimmune diseases. Two classical epigenetic markers-histone modifications and DNA cytosine methylation, the latter is the 5 position of the cytosine base in the context of CpG dinucleotides-play multiple roles in the immune system. CxxC domain-containing proteins, which basically bind to the non-methylated CpG (i.e., epigenetic "readers"), often function as "writers" of the epigenetic markers via their catalytic domain within the proteins or by interacting with other epigenetic modifiers. We herein report the most recent advances in our understanding of the functions of CxxC domain-containing proteins in the immune system and inflammation, mainly focusing on T cells and macrophages.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA methylation; helper T cells; ten-eleven translocation (TET) proteins; trithorax

Mesh:

Substances:

Year:  2021        PMID: 34935162     DOI: 10.1111/imr.13056

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  2 in total

Review 1.  Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis.

Authors:  Kota Kokubo; Atsushi Onodera; Masahiro Kiuchi; Kaori Tsuji; Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

2.  Editorial: Epigenetics of the immune component of inflammation.

Authors:  Yan-Jun Liu; Haitao Wang; Hai-Jing Zhong; Cheong-Meng Chong; Guan-Jun Yang
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.